These results suggest that nephrotic impairment is generally correlated with amyloid deposition, and the measurement of TTR in urine may become a possible biomarker to aid in diagnosing ATTRv V50M amyloidosis and in determining the degree of its progression [21]. This evidence concerns the gene TTR and amyloidosis.